Genomics of Brain Disorders

The aim of this meeting is to encourage practitioners of neuroscience, systems biology, bioinformatics, epidemiology and genomics to discuss and debate the challenges and opportunities that lie ahead in understanding the genomics of various brain disorders.

Psychiatric disorders, such as schizophrenia and depression, and neurodegenerative disorders, such as Alzheimer's disease and Parkinson’s disease, are placing an increasing burden on the developed world. Technical advances over the past five years, including genome-wide association studies and new generation sequencing studies, have led to the discovery of many predisposing loci for both psychiatric and neurodegenerative disorders.

This meeting will summarise the advances and remaining challenges in the genomics of various brain disorders, focusing on the lessons from each field and charting the way forward. They will discuss recent insights into genomic architecture and the emerging biology of disease. They will consider how best to gain biological understanding from both common and rare allele findings and explore the translational and clinical applications, focusing on early detection of risk, biomarkers and stratified medicine.

Scientific sessions:
• Genetic architecture
• Connecting genetics to biology
• Systems biology
• Population studies
• Modelling disease
• Predicting risk
• New technologies

The delegates are welcome abstracts from all areas relevant to the main themes of the meeting, for both oral and poster presentations. Several oral presentations will be chosen from the abstracts submitted.

Prices:
Student rates start from: GBP 290
Academic rates start from: GBP 390
Industry rates start from: GBP 490


Speakers: Alison Goate, John Hardy, Mike Owen, Pamela Sklar, Steven Hyman, Preben Bo Mortensen, Mark Cookson, Mark Daly, Bogdan Draganski, Kevin Eggan, Nick Fox, Dan Geschwind, Seth Grant, Thomas Nichols, Mina Ryten, Cornelia van Duijn, Naomi Wray